<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study, we investigated the regulation of CD44-hyaluronan (HA) interactions in a panel of EBV+ Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and lymphoblastoid B cell lines (B-LCL) generated by in vitro EBV transformation of <z:mpath ids='MPATH_458'>normal</z:mpath> human B cells </plain></SENT>
<SENT sid="1" pm="."><plain>The results show that among B cell <z:chebi fb="0" ids="52290">mitogens</z:chebi>, <z:chebi fb="0" ids="8116">phorbol</z:chebi> 12-<z:chebi fb="0" ids="30807">myristate</z:chebi> 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>) alone induced strong HA recognition in EBV+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-30/B95-8 cells </plain></SENT>
<SENT sid="2" pm="."><plain>Among the cytokines that affect B cell growth and differentiation, IL-4 alone induced HA recognition in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-30/B95-8 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Attempts to delineate the molecular mechanism for this increased HA <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-30/B95-8 cells revealed an enhanced expression of CD44 H, isoforms containing V3, V6, and V9 exons, alterations in the splicing pattern of the V4 exon, and the increased electrophoretic mobility of the CD44 H protein </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the ability to recognize HA was not observed in B-LCL cells stimulated with either <z:chebi fb="1" ids="53780">PMA</z:chebi> or IL-4, even though these cells respond to IL-4, as observed by upregulation of CD23 expression </plain></SENT>
<SENT sid="5" pm="."><plain>The molecular pathways that regulate CD44 expression and CD44-mediated HA binding may be selectively inactivated in B-LCL cells </plain></SENT>
<SENT sid="6" pm="."><plain>These results may have implications with respect to the generation and spread of B cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>